Artrya Ltd
ASX:AYA
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| AU |
A
|
Artrya Ltd
ASX:AYA
|
516.9m AUD |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
30.2B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
16.5B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.2T JPY |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
5.2B USD |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
40.1B SEK |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.2B USD |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
24.5B CNY |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
288.2B INR |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
Market Distribution
| Min | -16 177 900% |
| 30th Percentile | -544.7% |
| Median | -27.7% |
| 70th Percentile | 3.1% |
| Max | 3 174 540% |
Other Profitability Ratios
Artrya Ltd
Glance View
Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). The company is headquartered in Perth, Western Australia. The company went IPO on 2021-11-26. The firm is focused on operating diagnostic imaging center. The company is primarily engaged in providing powered image-analysis software for coronary artery disease. Its non-invasive solution, Salix uses artificial intelligence (AI) to produce a 3D image and report that provides an accurate detection of coronary artery disease, including the presence of vulnerable plaque. Salix offers precision medicine for cardiac care. The company enables clinicians to triage patients and identify individuals at high risk of heart attack. The firm's cardiac-health report provides diagnostic support to radiologists and cardiologists.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Artrya Ltd is -58 592.9%, which is above its 3-year median of -85 304.1%.
Over the last 4 months, Artrya Ltd’s Net Margin has increased from -112 015.4% to -58 592.9%. During this period, it reached a low of -112 015.4% on Jan 31, 2025 and a high of -58 592.9% on Jun 30, 2025.
